Literature DB >> 31597467

Prognostic Value of Low Flow in Patients With High Transvalvular Gradient Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction: A Multicenter Study.

Sylvestre Maréchaux1,2, Dan Rusinaru2,3, Alexandre Altes1, Agnès Pasquet4,5, Jean Louis Vanoverschelde4,5, Christophe Tribouilloy2,3.   

Abstract

BACKGROUND: Grading of severe (aortic valve area ≤1 cm2) aortic stenosis with preserved left ventricular ejection fraction is based on a classification depending on flow (normal flow versus low flow) and pressure gradient (low gradient versus high gradient). The aim of the present study was to compare the outcome of patients with normal flow high gradient and low flow high gradient severe aortic stenosis (SAS) with no or minimal symptoms.
METHODS: This multicenter study enrolled 983 consecutive patients (mean age 75±11 years, 459 women) with asymptomatic or minimally symptomatic HG (mean pressure gradient ≥40 mm Hg) SAS with preserved left ventricular ejection fraction. Low flow was defined by Doppler echocardiography as a stroke volume index <30 mL/m2 (n=131) or a stroke volume <55 mL (n=136). The end point was all-cause mortality.
RESULTS: During a median follow-up period of 48 (45-52) months, 225 patients (23%) died. The 60-month mortality was higher in low flow high gradient SAS compared with normal flow high gradient SAS (36±5% versus 22±2% and 38±5% versus 21±2% for stroke volume index and stroke volume, respectively, both P<0.0001). After adjustment for outcome predictors including aortic valve replacement as time-dependent covariate, low flow high gradient SAS displayed considerable mortality risk during follow up compared with normal flow high gradient SAS (adjusted HR 2.17 [1.51-3.13]; P<0.0001 for stroke volume index <30 mL/m2 and adjusted HR 1.86 [1.29-2.68]; P=0.001, for stroke volume <55 mL). The prognostic impact of low flow was consistent in subgroups of patients.
CONCLUSIONS: Asymptomatic or minimally symptomatic patients with low flow high gradient SAS and preserved left ventricular ejection fraction have a considerable increased risk of mortality during follow-up. These patients should be promptly considered for aortic valve replacement.

Entities:  

Keywords:  aortic valve; echocardiography, doppler; prognosis; stroke volume

Year:  2019        PMID: 31597467     DOI: 10.1161/CIRCIMAGING.119.009299

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  5 in total

Review 1.  Review: application of current imaging modalities in the management of left-sided valvular heart disease.

Authors:  Robert Zheng; Kenya Kusunose
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

2.  Relationship Between the Ratio of Acceleration Time/Ejection Time and Mortality in Patients With High-Gradient Severe Aortic Stenosis.

Authors:  Alexandre Altes; Nicolas Thellier; Yohann Bohbot; Anne Ringle Griguer; Stéphane Verdun; Franck Levy; Anne Laure Castel; François Delelis; Amandine Mailliet; Christophe Tribouilloy; Sylvestre Maréchaux
Journal:  J Am Heart Assoc       Date:  2021-11-30       Impact factor: 5.501

Review 3.  Multimodality Imaging for Discordant Low-Gradient Aortic Stenosis: Assessing the Valve and the Myocardium.

Authors:  Ezequiel Guzzetti; Mohamed-Salah Annabi; Philippe Pibarot; Marie-Annick Clavel
Journal:  Front Cardiovasc Med       Date:  2020-12-03

4.  Predicting Long-Term Mortality in TAVI Patients Using Machine Learning Techniques.

Authors:  Marco Penso; Mauro Pepi; Laura Fusini; Manuela Muratori; Claudia Cefalù; Valentina Mantegazza; Paola Gripari; Sarah Ghulam Ali; Franco Fabbiocchi; Antonio L Bartorelli; Enrico G Caiani; Gloria Tamborini
Journal:  J Cardiovasc Dev Dis       Date:  2021-04-16

5.  Echocardiographic Investigation of Low-Flow State in a Hispanic/Latino Population.

Authors:  Patrick M Kozak; Min Pu; Katrina Swett; Martha L Daviglus; Mayank M Kansal; Daniela Sotres-Alvarez; Sonia G Ponce; Robert Kaplan; Mario Garcia; Carlos J Rodriguez
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2022-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.